Literature DB >> 11064496

Causes and rates of death among methadone maintenance patients before and after the onset of the HIV/AIDS epidemic.

P W Appel1, H Joseph, B L Richman.   

Abstract

Causes of death and the mortality rates of active methadone patients and those who had left treatment were compared. Prior to the HIV epidemic, death rates among discharged methadone patients were more than twice that of patients who continued with their methadone treatment. However, the death rate from heroin-related causes in the post-treatment period was 51 times the rate among active patients. Alcohol-related conditions were the leading causes of death in patients more than 30 years old on methadone. During the post-treatment period, alcohol-related deaths were second to those of heroin-related causes. Alcohol-related deaths were particularly pronounced among black patients. Death rates among active male and female patients were identical, but the death rate for discharged female patients was greater than for discharged males. With the onset of the HIV epidemic in the 1980s, AIDS-related causes became the major cause of death in treatment. However, other causes of death, such as alcohol and other medical conditions, identified prior to the AIDS epidemic, persisted. AIDS-related deaths peaked in the mid-1990s and have recently subsided. However, within the past two years, deaths related to HCV have increased to 9% of all patient deaths in a major methadone program. With the emergence of HCV, deaths from this cause are expected to eclipse AIDS-related deaths within the next decade.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11064496

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  7 in total

1.  Problem drinking and low-dose naltrexone-assisted opioid detoxification.

Authors:  Paolo Mannelli; Kathleen Peindl; Ashwin A Patkar; Li-Tzy Wu; Haresh M Tharwani; David A Gorelick
Journal:  J Stud Alcohol Drugs       Date:  2011-05       Impact factor: 2.582

2.  A comparative study of mortality among Puerto Rican injection drug users in East Harlem, New York, and Bayamon, Puerto Rico.

Authors:  Hector Manuel Colon; Sherry Deren; Rafaela Rivera Robles; Sung-Yeon Kang; Myrna Cabassa; Hardeo Sahai
Journal:  J Urban Health       Date:  2006-11       Impact factor: 3.671

Review 3.  Pharmacotherapy of dual substance abuse and dependence.

Authors:  George A Kenna; Darci M Nielsen; Patricia Mello; Alison Schiesl; Robert M Swift
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

4.  Primary care and medication management characteristics among patients receiving office-based opioid treatment with buprenorphine.

Authors:  Cindy Xinxin Du; Julia Shi; Jeanette M Tetrault; Lynn M Madden; Declan T Barry
Journal:  Fam Pract       Date:  2022-03-24       Impact factor: 2.267

5.  Morbidity and mortality profile of human immunodeficiency virus-infected patients with and without hepatitis C co-infection.

Authors:  Angel M Mayor; Maria A Gomez; Diana M Fernandez; Eddy Rios-Olivares; James C Thomas; Robert F Hunter
Journal:  Am J Trop Med Hyg       Date:  2006-02       Impact factor: 2.345

6.  The feasibility and acceptability of a multimedia hepatitis C prevention program for Hispanic HIV-infected persons.

Authors:  Angel M Mayor; Diana M Fernández; Héctor M Colón; James C Thomas; Robert F Hunter-Mellado
Journal:  Ethn Dis       Date:  2008       Impact factor: 1.847

7.  Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis.

Authors:  Jun Ma; Yan-Ping Bao; Ru-Jia Wang; Meng-Fan Su; Mo-Xuan Liu; Jin-Qiao Li; Louisa Degenhardt; Michael Farrell; Frederic C Blow; Mark Ilgen; Jie Shi; Lin Lu
Journal:  Mol Psychiatry       Date:  2018-06-22       Impact factor: 15.992

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.